a study to evaluate the safety and immunogenicity of a yeast derived recombinant dna hepatitis b vaccine ( engerix-b ) was conducted in healthy newborn infants born to low risk european mothers negative for hepatitis b surface antigen ( hbsag ) .
C0062527
recombinant
C0116078
engerix-b